MBX Biosciences receives IND approval in USA for hypoglycemia.
In: R & D Focus Drug News, 2023-08-10
serialPeriodical
Zugriff:
Titel: |
MBX Biosciences receives IND approval in USA for hypoglycemia.
|
---|---|
Zeitschrift: | R & D Focus Drug News, 2023-08-10 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1350-1135 (print) |
Sonstiges: |
|